PET/CT in brain disorders /
Saved in:
Imprint: | Cham, Switzerland : Springer, [2019] |
---|---|
Description: | 1 online resource (xvii, 178 pages) : illustrations (some color) |
Language: | English |
Series: | Clinician's guides to radionuclide hybrid imaging, PET/CT, 2367-2439 Clinicians' guides to radionuclide hybrid imaging. PET/CT. |
Subject: | Brain -- Diseases -- Tomography. Neuroimaging -- methods. Medical radiology. Neurology. Nuclear medicine. Electronic books. |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11851860 |
Table of Contents:
- Intro; Foreword; Preface; Acknowledgements; Contents; Contributors; 1: Introduction to Brain Disorders; References; 2: Radiological Imaging in Brain Disorders: An Overview; 2.1 Neuroimaging Modalities and Techniques; 2.1.1 Computed Tomography (CT); 2.1.2 Magnetic Resonance Imaging (MRI); 2.1.2.1 Perfusion MRI; 2.1.2.2 MR Spectroscopy; 2.1.2.3 Diffusion Tensor Imaging; 2.1.2.4 Functional MRI (f-MRI); 2.2 Radiological Imaging in Neurodegenerative Diseases; 2.3 Radiological Imaging in Movement Disorders; 2.4 Radiological Imaging in Epilepsy; 2.5 Radiological Imaging in Neuro-Oncology
- 5.3 Frontotemporal Degeneration (FTD)5.4 Dementia of Lewy Body (DLB); 5.5 Other Neurodegenerative Diseases; 5.6 Advantages and Limitations; References; 6: [18F]FDG-PET/CT in Movement Disorders; 6.1 Introduction; 6.2 Parkinson's Disease; 6.2.1 Clinical Phenotypes; 6.2.2 Neuropathology Findings; 6.2.3 [18F]FDG-PET Typical Patterns; 6.3 Multiple System Atrophy; 6.3.1 Clinical Phenotypes; 6.3.2 Neuropathology Findings; 6.3.3 [18F]FDG-PET Typical Patterns; 6.4 The Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration; 6.4.1 Clinical Phenotypes
- 6.4.2 Neuropathology Findings6.4.3 [18F]FDG-PET Typical Patterns; 6.5 Huntington's Disease; 6.5.1 Clinical Phenotypes; 6.5.2 Neuropathology Findings; 6.5.3 [18F]FDG-PET Typical Patterns; 6.6 Advantages and Limitations; 6.6.1 General Advantages; 6.6.2 General Limitations; References; 7: 18F-FDG PET in Epilepsy; 7.1 Introduction; 7.2 Clinical Indications; 7.3 Classical Patterns; 7.3.1 Temporal; 7.3.2 Extratemporal; 7.3.3 Syndromes; 7.4 Advantages and Limitations; 7.5 Conclusion; References; 8: PET in Neuro-Oncology; 8.1 Introduction
- 8.2 PET in Primary Glioma Diagnosis and Differential Diagnosis8.2.1 18F-FDG; 8.2.2 11C-MET; 8.2.3 18F-FET; 8.2.4 18F-FDOPA; 8.2.5 18F-CHO; 8.2.6 18F-FLT; 8.3 Amino Acid Tracers PET in Glioma Histological Subtyping; 8.4 PET in Glioma Grading; 8.4.1 18F-FET; 8.4.2 11C-MET; 8.4.3 18F-FDOPA; 8.4.4 18F-FLT; 8.5 Glioma Treatment Effect and Recurrence; 8.6 PET Tracers in Differentiating Recurrence from Treatment Effects; 8.7 Conclusion; References; 9: 18F-FDG PET/CT Indications, Pitfalls and Limitations in Brain Imaging; 9.1 Introduction; 9.2 Indications